Retatrutide

What is Retatrutide? Retatrutide is a triple-agonist research peptide — one engineered molecule with agonist activity at the GLP-1, GIP, and glucagon receptors. That three-receptor footprint sets it apart from the dual agonists that preceded it and has made it one of the most closely watched molecules in metabolic-pathway research. ## Why researchers choose it One backbone engaging three receptors lets a protocol probe overlapping signalling cascades with a single, well-characterised input — the readout reflects integrated activity instead of three experiments stitched together. REPRIME supplies retatrutide as lyophilized powder in 10 mg, 20 mg, and 30 mg vials, leaving reconstitution timing and concentration entirely under the researcher's control. ## The REPRIME standard Confidence here is documented, not promised. Every batch is tested by an independent laboratory and released at ≥99% HPLC main-peak purity; the full COA and chromatogram are published on this page before you order. Each vial ships cold-chain in a tamper-evident pouch with a unique REP-XXXX-XXXX-X code — scan it at first use to confirm your unit is authentic. For laboratory and research use only; not for human consumption.